AIRDUO Drug Patent Profile
✉ Email this page to a colleague
When do Airduo patents expire, and when can generic versions of Airduo launch?
Airduo is a drug marketed by Teva Pharm and is included in one NDA. There are seven patents protecting this drug.
The generic ingredient in AIRDUO is fluticasone propionate; salmeterol xinafoate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Airduo
A generic version of AIRDUO was approved as fluticasone propionate; salmeterol xinafoate by HIKMA on December 17th, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AIRDUO?
- What are the global sales for AIRDUO?
- What is Average Wholesale Price for AIRDUO?
Summary for AIRDUO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for AIRDUO |
| DailyMed Link: | AIRDUO at DailyMed |
US Patents and Regulatory Information for AIRDUO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharm | AIRDUO RESPICLICK | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-003 | Jan 27, 2017 | RX | Yes | Yes | 10,195,375*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Teva Pharm | AIRDUO RESPICLICK | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-003 | Jan 27, 2017 | RX | Yes | Yes | 11,969,544*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-004 | Jul 12, 2019 | DISCN | Yes | No | 11,173,259*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
